from 21 to 23 May, Barcelona, Spain
The Emitech Group will be present at the IoT World Congress from 21 to 23 May in Barcelona.
The Emitech Group will be present at the IoT World Congress from 21 to 23 May in Barcelona.
from 21 to 23 May, Barcelona, Spain
The Emitech Group will be present at the IoT World Congress from 21 to 23 May in Barcelona.
Within the framework of the CB scheme, Emitech's international certification service has just been recognized as a NCB (National Certification Body). lt can now manage laboratories in the network, the CBTL (Certification Body Testing Laboratory), and deliver thanks to their reports, CB certificates recognized in the member countries.
Within the framework of the CB scheme, Emitech's international certification service has just been recognized as a NCB (National Certification Body). lt can now manage laboratories in the network, the CBTL (Certification Body Testing Laboratory), and deliver thanks to their reports, CB certificates recognized in the member countries.
During this covid19 alert period, our laboratories and services remain open and ready to welcome you while taking sanitary measures to protect you and our teams.
In particular, gloves, masks and hydroalcoholic gel are made available to you.
During this covid19 alert period, our laboratories and services remain open and ready to welcome you while taking sanitary measures to protect you and our teams.
In particular, gloves, masks and hydroalcoholic gel are made available to you.
Risk management is at the heart of medical device safety assessment and a manufacturer is required to perform an assessment based on the requirements of the standard in combination with the risk identified by the manufacturer. It would not be useless for any electromedical product that could be exposed to RFID to include these tests for immunity to specific frequencies and modulations in its assessment.
Risk management is at the heart of medical device safety assessment and a manufacturer is required to perform an assessment based on the requirements of the standard in combination with the risk identified by the manufacturer. It would not be useless for any electromedical product that could be exposed to RFID to include these tests for immunity to specific frequencies and modulations in its assessment.
Sujet sur les dispositifs médicaux (DM)
Le Groupe EMITECH qui compte désormais 4 filiales avec l'acquisition de DIRAC TECHNOLOGY en début d'année, poursuit son développement conformément à sa stratégie de services de proximité, de réactivité et de qualité avec la création d'un nouveau laboratoire à Toulouse.
Emitech Group - Legal information